Acamprosate Completed Phase 4 Trials for Alcohol Dependence / Generalized Anxiety Disorder (GAD) / Major Depressive Disorder (MDD) / Social Anxiety Disorder (SAD) Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00435435Comparative Trial Of Disulfiram, Naltrexone And Acamprosate In The Treatment Of Alcohol Dependence
NCT00381043Study of Campral (Acamprosate) for Alcohol Dependence in a Family Medicine Clinic
NCT00330174Acamprosate in Alcoholics With Comorbid Anxiety or Depression